Cure InsomniaImprove Anxiety and Insomnia
Cytocraft III Cells
A Viable Technique for Improving Manic Depression
Activating Factors, Improving Manic Depression, Anxiety and Insomnia
In response to nervous system sub-health, the T cells activated by special pathways (Cytocraft-3 cells) can secrete a large number of nerve factors, such as NGF, NT3/NT4, BDNF, and these nerve factors can promote the recovery of nervous system. In addition, Cytocraft-3 cells contain neurotransmitter receptors similar to nerve cells, which can regulate nerve function. According to the clinical trial treatments performed at the Immunotherapy Research Center in Munich, Germany, Cytocraft-3 cells can improve the symptoms of manic depression, and can also improve general sub-health status, such as anxiety and insomnia.
The History of Research on Cytocraft III Cells for Improving the Symptoms of Manic Depression
In 1999, it was first discovered that Th1/Th2-polarized T lymphocytes can secrete neuronal factors and nerve growth factors.
In 2002, it was proposed that mental disorders need long-term immunotherapy.
In 2005, activated immune cells (Cytocraft-3 cells) were used for the treatment of manic depression, and the treatment was successful.
In 2011, it was proposed that mental disorders are associated with long-term subclinical infection of chlamydia.
In 2013, the Cytocraft-3 cell technique was invented
In 2013, it was discovered that mental disorders are associated with the abnormal regulation of lymphocyte factor (interferon gamma) after infection.
In 2017, activated immune cells (Cytocraft-3 cells) were used to awaken patients in a long-term vegetative state, and the treatment was successful.
In 2017, activated immune cells (Cytocraft-3 cells) were used to treat Alzheimer's disease, and the treatment was successful.
2019©LifeBank Biotech Co., Ltd.Powered by SE